Latest features in GaBI Journal, 2015, Issue 3
Advances in analytical characterization of biosimilars
Access to safe and effective biopharmaceuticals
The challenges of nomenclature – INN, biosimilars and biological qualifiers
Biosimilars patent litigation in the EU and the US: a comparative strategic overview
Biosimilars: extrapolation of clinical use to other indications
The implementation of generics in France
Substantial savings with generics in Austria – and still room for more
European biosimilars conference highlights extrapolation as key issue
Regulatory requirements for the development and registration of biosimilars in South Africa
Source URL: https://gabi-journal.net/20153-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.